Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells
Chuangyu Wen(University of Chicago), Xiangling Yang(Sun Yat-sen University), Ping Lan(Sun Yat-sen University), Daici Chen(Sun Yat-sen University), Huanliang Liu(Sun Yat-sen University), Zerong Cai(Sun Yat-sen University), Aikichi Iwamoto(Tokyo University of Science), Lu He(Hubei University of Medicine), Di Zhang(Sun Yat-sen University), Huihui Wang(University of Shanghai for Science and Technology), Lei Wang(Sun Yat-sen University), Jianping Wang(Translational Therapeutics (United States)), Lan Huang(81th Hospital of PLA), Jia Che(Sun Yat-sen University), Donglin Ren(Sun Yat-sen University), Junxiong Chen(Sun Yat-sen University), Qiong Lou(Sun Yat-sen University), Mengmeng Lin(Sun Yat-sen University), Qiyuan Qin(Sun Yat-sen University)
Cited by 36
Related Papers
Predicting 30-days mortality for MIMIC-III patients with sepsis-3: a machine learning approach using XGboost
|Journal of Translational Medicine|2020|614
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
|Cell stem cell|2013|412
LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization
|Cell Death and Disease|2019|404
Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study
|The Lancet Digital Health|2021|334
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2021|304